Drug-free device to control premature ejaculation: Buy online

  • Facebook
  • Twitter
  • Reddit
  • Flipboard
  • Email
  • WhatsApp
Representational Image
Representational Image

New Delhi : When it comes to men’s health, premature ejaculation is a serious concern. It not only affects sexual life but also creates embarrassing situation for the person who suffers from this problem. To help control premature ejaculation, health experts have designed a drug-free device which helps men reduce over-sensitivity during sex and enables them to control ejaculation.

Named as Prolong, this device is powered by a 3-volt motor and is available online at $300 after it was approved by the US Food and Drug Administration.

Prolong, which is small plastic vibrating "cup", is a part of a six-week "controlled climax" program. It helps reduce over-sensitivity during sex and enables men to control their ejaculation. The device can be used to stimulate the penis during masturbation. When the user reaches climax, the device should be stopped and he should control the urge to ejaculate.

"This 'start-stop' process is repeated three times in total, then on the third time the user is free to ejaculate if they wish. This process is repeated three times a week for six weeks," said Dr Andy Zamar – the creator of the device, London Psychiatry Centre founder and psychiatrist, according to news.com.au.

InnovaDerma – the company behind the device claims that powered by a 3-volt motor, Prolong has been designed by InnovaDerma. It can help to delay ejaculation from 48 seconds to eight minutes and 48 seconds, according to the website.

A clinical trial has been conducted on 58 participants, which showed the positive results in 61 percent of men, on average.

"In another clinical trial, participants using Prolong achieved a median increase in time to ejaculation of 3 minutes. In a third trial conducted in Finland, 11 highly resistant lifelong sufferers of PE [premature ejaculation] aged on average 49 years old used the Prolong program. Participants had previously failed to respond to or could not tolerate multiple drug treatments. Out of the 11 subjects, eight improved and maintained their improvement or improved further at six months." Said the company in a statement, as reported.